Search

everythinglearnresearchcommunity

for

Search:↓

Eyelashes are important for looks and eye protection, and more people are treating sparse eyelashes; more research is needed to understand eyelash biology and improve treatments.

Women with PCOS often have irregular periods, a higher chance of infertility and miscarriages, and may improve fertility with lifestyle changes and treatment.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

The Foxn1 gene mutation causes hairlessness and immune system issues, and understanding it could lead to hair growth disorder treatments.

Nearly half of the French individuals surveyed reported having a sensitive scalp, more common in women, often linked to hair loss and symptoms like itching, and triggered by factors including shampoos and pollution.

Platelet-rich plasma may help in skin and hair treatments, and with muscle and joint healing, but more research is needed to fully understand its benefits and limitations.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Finasteride improves hair density and thickness in women with hair loss.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Spironolactone plus finasteride reduces hirsutism more effectively.

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

The pseudo 'fringe sign' can also appear in frontal fibrosing alopecia, not just in traction alopecia, showing that this condition may be more common than thought.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

Female hair loss linked to metabolic syndrome, not in males.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

There is no significant link between male pattern baldness and insulin resistance.

IGF-1 affects hair loss and could be a potential treatment.

African American women report more hair issues and use different hair care practices than Caucasian women, and have different hair and scalp characteristics.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

CD10 and CD34 levels change during hair development and different hair growth stages, which could be important for hair regeneration treatments.

Finasteride lowers scalp and blood DHT levels, potentially treating male-pattern baldness.